Home Clinical Topics Cardio-Pulmonary FDA approves new drug for heart failure

FDA approves new drug for heart failure

On July 7, the U.S. Food and Drug Administration (FDA) approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here